Apollon Wealth Management’s ProPhase Labs PRPH Stock Holding History

Apollon Wealth Management’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,246	Closed	-$83.5K	–	1371
2025 Q3	$83.5K	Buy	+18,246	New	+$70.5K	﹤0.01%	1277

Other funds holding PRPH

Sykon Capital Harrison, New York $325M AUM 19.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Apollon Wealth Management's PRPH Position: Q4 2025 in Review

Apollon Wealth Management sold out of ProPhase Labs (PRPH) in Q4 2025, closing a stake of 18,246 shares — an estimated $83.5K sold.

Apollon Wealth Management first reported a position in PRPH in Q3 2025 and held it in 1 quarter. The position peaked at $83.5K in Q3 2025. 17 funds tracked by Wall St. Rank hold PRPH as of Q4 2025.

Apollon Wealth Management reported no remaining ProPhase Labs position as of Q4 2025 after selling out during the quarter.
Apollon Wealth Management sold 18,246 ProPhase Labs shares in Q4 2025, an estimated $83.5K.
Apollon Wealth Management first reported a position in ProPhase Labs in Q3 2025 and held it in 1 quarter.
Apollon Wealth Management's ProPhase Labs position peaked at $83.5K in Q3 2025.
17 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2025.

Based on Apollon Wealth Management's 13F filing for Q4 2025, filed 22 Jan 2026.